Seelos Therapeutics, Inc. (SEEL)
NASDAQ: SEEL · IEX Real-Time Price · USD
0.546
+0.022 (4.28%)
At close: Jul 19, 2024, 4:00 PM
0.540
-0.006 (-1.08%)
Pre-market: Jul 22, 2024, 7:21 AM EDT
Seelos Therapeutics Stock Forecast
SEEL's stock price has decreased by -99.86% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Seelos Therapeutics stock has a target of 240, which predicts an increase of 43,864.10% from the current stock price of 0.55.
Analyst Consensus: Hold
* Price targets were last updated on Sep 21, 2023.
Analyst Ratings
The average analyst rating for SEEL stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 22, 2023 |
Benchmark | Benchmark | Buy Maintains $960 → $240 | Buy | Maintains | $960 → $240 | +43,864.10% | Sep 21, 2023 |
Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 21, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 21, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $480 | Buy | Reiterates | $480 | +87,828.19% | Aug 22, 2023 |
Financial Forecast
Revenue This Year
306.00K
from 2.20M
Decreased by -86.11%
Revenue Next Year
28.97M
from 306.00K
Increased by 9,366.67%
EPS This Year
-1.34
from -61.84
EPS Next Year
-0.33
from -1.34
Revenue Forecast
Revenue | 2024 | 2025 |
---|---|---|
High | 945,000 | 29.8M |
Avg | 306,000 | 29.0M |
Low | n/a | 27.8M |
Revenue Growth
Revenue Growth | 2024 | 2025 |
---|---|---|
High | -57.1% | 9,645.1% |
Avg | -86.1% | 9,366.7% |
Low | - | 8,995.4% |
EPS Forecast
EPS | 2024 | 2025 |
---|---|---|
High | -1.38 | -0.34 |
Avg | -1.34 | -0.33 |
Low | -1.28 | -0.31 |
EPS Growth
EPS Growth | 2024 | 2025 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.